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Available online 27 July 2014Abstract Pancreatic Lgr5 expression has been associated with organoid-forming epithelial progenitor populations but the identity
of the organoid-initiating epithelial cell subpopulation has remained elusive. Injury causes the emergence of an Lgr5+
organoid-forming epithelial progenitor population in the adult mouse liver and pancreas. Here, we define the origin of
organoid-initiating cells from mouse pancreas and liver prior to Lgr5 activation. This clonogenic population was defined as
MIC1-1C3+/CD133+/CD26− in both tissues and the frequency of organoid initiation within this population was approximately 5% in each
case. The transcriptomes of these populations overlapped extensively and showed enrichment of epithelial progenitor-associated
regulatory genes such as Sox9 and FoxJ1. Surprisingly, pancreatic organoid cells also had the capacity to generate hepatocyte-like cells
upon transplantation to Fah−/− mice, indicating a differentiation capacity similar to hepatic organoids. Although spontaneous
endocrine differentiation of pancreatic progenitors was not observed in culture, adenoviral delivery of fate-specifying factors Pdx1,
Neurog3 andMafA induced insulin expressionwithout glucagon or somatostatin. Pancreatic organoid cultures therefore preservemany
key attributes of progenitor cells while allowing unlimited expansion, facilitating the study of fate determination.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).Abbreviations: FACS, fluorescence-activated cell sorting.
☆ Grant support: This work was supported by National Institutes of
Health grant DK051592 (M.G.) and DK089569 (P.S. and M.G.).
⁎ Corresponding author at: OregonHealth& Science University, 3181
SW Sam Jackson Park Rd., Mail code L-321, Portland OR, USA, 97239.
E-mail address: grompem@ohsu.edu (M. Grompe).
http://dx.doi.org/10.1016/j.scr.2014.07.006
1873-5061/© 2014 The Authors. Published by Elsevier B.V. This is an ope
(http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
The potential for progenitor-driven hepatic and/or pancre-
atic organ regeneration is of significant interest for
regenerative medicine. Expression of the R-spondin receptor
Lgr5 and activation of the Wnt signaling pathway have beenn access article under the CC BY-NC-SA license
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(Barker et al., 2010; Sato et al., 2009). Epithelial Lgr5+ cells are
highly clonogenic, initiating self-renewing organoids that can
retain differentiation potential despite many rounds of pas-
sage/expansion and therefore fulfilling the formal criteria for
stem cells. Although Lgr5 is not expressed in uninjured adult
liver or pancreas, expression of this marker has been shown to
be induced following tissue damage (Huch et al., 2013b). Lgr5+
cells recovered from injured mouse liver form organoids and
yield hepatocytes after transplantation and appropriate selec-
tion (Huch et al., 2013b). Similarly, Lgr5+ cells from the adult
mouse pancreas can establish organoid cultures (Huch et al.,
2013a). In both tissues, the precursor cell capable of producing
the Lgr5+ population upon injury remains poorly characterized.
Several groups, including ours, have reported the cell
surface signature of a biliary duct-resident clonogenic progen-
itor in the mouse liver (Dorrell et al., 2011; Shin et al., 2011;
Suzuki et al., 2008). Our identification employed a clonogenic
assay based on two-dimensional growth on conventional tissue
culture surfaces, and the self-renewal capacity of progenitors
defined by this method was inherently limited. However, given
the ability of progenitor-derived cells to express characteristic
hepatocyte genes in vitro, we surmised that this population
contained (and retained) meaningful differentiation potential.
The pancreas and liver share developmental origins
(Kawaguchi, 2013; Zaret and Grompe, 2008) and the ductal
epithelial cells in these adult organs have similar functions and
morphological appearance. The appearance of hepatocyte-like
cells in the pancreata of rats fed a copper-deficient diet (Rao et
al., 1986) illustrates the potential for transdifferentiation
between cell types from these organs. In mice, the transplan-
tation of pancreatic cells has been shown to yield functional
hepatocytes in Fah−/− recipients (Wang et al., 2001). These
embryological and functional similarities as well as the
existence of an injury induced Lgr5+ population in both tissues
raised the possibility that the adult mouse pancreas and liver
may harbor a common endodermal progenitor.
In this report we describe the phenotypic definition and
FACS-based isolation of a clonal progenitor present at similar
frequencies in both the pancreas and liver of adult mice.
This hepato-pancreatic MIC1-1C3+/CD133+/CD26− (hereafter
M+133+26−) population initiates organoid cultures with unlim-
ited self-renewal potential. The gene expression profiles of
these populations revealed that factors such as Sox9 are
enriched in both organoid-forming populations in a pattern
consistent with the regulation of progenitor function. When
single cells from the pancreatic M+133+26− population were
examined, heterogeneous expression of Sox9 was observed,
suggesting a correlation with organoid-forming capacity.
Remarkably, transplantation of organoids derived from sorted
pancreatic M+133+26− cells yielded hepatocyte-like cell grafts
in the livers of 5/10 of recipient mice, indicating that this
population retains important differentiation potential even
after massive expansion in culture. Furthermore, M+133+26−
organoid cultures yielded insulin-expressing cells after induc-
tion of Pdx1/Neurog3/MafA expression, suggesting that a
capacity for endocrine differentiation was also retained. The
gene expression profiles of the progenitor-enriched populations
characterized here reveal new information regarding the
nature and potential of adult epithelial progenitors, and may
guide future efforts to enhance their activity in situ or to
control their fate during ES/iPS cell differentiation.Materials and methods
Tissue sources and pancreatic cell isolation
Animal care and immunization procedures were performed
in accordance with protocol IS00000119 of the institutional
review committee at Oregon Health & Science University.
C57Bl/6 mice, obtained from the Jackson Laboratory, were
fed a Purina 5015 diet. For transplantation studies, Fah−/−
C57Bl/6 recipient animals were used (Grompe et al., 1993).
Immunofluorescent imaging
Mouse pancreatic cryosections (5 μm) were prepared using a
Reichert 2800 Frigocut (Reichert Scientific Instruments) and
preserved in acetone for 10′ at −20 °C. Non-specific labeling
was blocked by pre-incubation in 2% goat serum (Hyclone)
for 10′. Antibodies used included anti-CD49c (R&D Systems)
and rabbit anti-mouse Fah (Overturf et al., 1996). Primary
labeling employed hybridoma supernatants diluted 1:20 in
DPBS for 30 min and secondary labeling with 1:200 dilutions
of Cy3-conjugated anti-rat Ig pre-adsorbed against mouse
serum proteins (Jackson ImmunoResearch, West Grove, PA)
for 20 min. Nuclei were visualized with Hoechst 33342
(Molecular Probes, Eugene, OR). A Zeiss Axioskop 2 plus
microscope (Carl Zeiss, Jenna, Germany) was used for
imaging.
Flow cytometry and FACS
Dissociated cells were resuspended at 1 × 106 cells/ml in
DMEM + 2% FBS prior to the addition of MIC1-1C3 hybridoma
supernatant (at a 1:20 dilution) or a 1:200 dilution of purified
MIC1-1C3 antibody (Novus) and incubation at 4 °C (for 30′).
After a wash with cold DPBS, cells were resuspended in
DMEM + 2% FBS containing a 1:200 dilution of APC-conjugated
goat anti-rat secondary antibody adsorbed against mouse serum
proteins (Jackson ImmunoResearch). After another wash, cells
were resuspended in DMEM + 5% rat serum (Serotec) and held
on ice (10′) to block the secondary antibody. A final incubation
with FITC-conjugated anti-CD26 (BD Biosciences, Franklin
Lakes, NJ), PE-conjugated anti-CD133 (eBioscience, San Diego,
CA) and PE-Cy7-conjugated anti-CD45 (BD Biosciences) + anti-
CD11b/Mac1 (BD Biosciences) + anti-CD31 (Abcam, Cambridge,
MA) facilitated cell subfractionation and exclusion gating of
hematopoietic (CD45+, CD11b+) and endothelial (CD31+) cells.
Propidium iodide staining was used to label dead cells for
exclusion. Cells were analyzed and sorted with a Cytopeia
inFluxV-GS (Becton-Dickenson, Franklin Lakes, NJ); FSC:
Pulse-width gating was used to exclude cell doublets from
analysis and collection.
Organoid formation assay
Mouse pancreatic and hepatic organoids were initiated,
cultured and cryopreserved as described previously (Huch et
al., 2013b) with minor modifications. Gastrin was omitted
from the culture media and constitutive administration of
ALK5 inhibitor SB431542 (Tocris) was added. For organoid
cultures initiated by single FACS-sorted cells, 5% Matrigel
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deposited into this mixture. The organoids initiated in these
cultures were passaged into “standard” organoid conditions
(embedding in N95% Matrigel followed by the addition of
liquid media) after two weeks of growth.
Adenoviral transduction of organoid cultures
For reprogramming studies, pancreatic organoid cultures were
initiated from an MIP-GFP transgenic mouse pancreas (Hara et
al., 2003). Prior to transduction, organoidswere recovered from
Matrigel, fragmented by mechanical disruption with a p1000
pipetter (Rainin) and seeded on collagen-coated plasticware in
organoid expansion media. Eight hours later, tri-cistronic
adenovirus encoding mouse Pdx1, Neurog3 and MafA (ad-PNM)
generously provided by the laboratory of Jonathan Slack was
added at an MOI of 1:10. The media were changed after an
over-night transduction, and the emergence of GFP expression
was monitored by fluorescence microscopy. After 72 h, cells
were recovered by exposure to 0.05% trypsin (Hyclone) and
evaluated by flow cytometry and qRT-PCR (described below).
Cell capture and cDNA preparation from individual
cells using the Fluidigm C1
Approximately 2000 MIC1-1C3+CD133+CD26−CD45−CD31−
CD11b− cells were isolated from an ActB-GFP transgenic
mouse pancreas by FACS as described above. These were
then loaded onto a 10–17 μm C1 Single-Cell Auto Prep IFC
chamber (Fluidigm), and cell capture was performed
according to the manufacturer's instructions. Capture
efficiency was 86% (83/96 wells occupied with a single cell)
as determined by fluorescent microscopy. Both the empty
wells (8) and doublet-occupied wells (5) were noted and
excluded from further analysis. Upon capture, reverse tran-
scription and cDNA pre-amplification were performed in the
10–17 μmC1 Single-Cell Auto Prep IFC using the SMARTer Ultra
Low RNA and Advantage 2 PCR kits (Clontech). cDNA was then
harvested and assessedwith an Agilent Bioanalyzer at theOHSU
Massively Parallel Sequencing Core. Yielded cDNA con-
centration was 500–700 pg/μl and the average size was
approximately 1.5 kb.
Transplantation assay
The injection of sorted cell populations into the spleen and
the withdrawal of NTBC to induce hepatocyte selection were
performed as previously described (Overturf et al., 1996),
with additional procedures listed in Fig. 3A. Drug withdrawal
was performed in cycles of approximately three weeks,
terminated when the weight of the recipient mouse dropped
below 80% of its pre-surgical level. NTBC was then
re-administered until normal weights were restored.
Limiting dilution analysis
For limiting dilution assays of organoid formation, Poisson
statistics for the single-hit model were applied. Cells were
seeded at densities ranging from 1 to 25 per well and counts
were performed at d12.Antigen identification by mass spectrometry
Whole cell extracts from H2.35 cell lines were fractionated by
SDS-PAGE on a 10% Bis-Tris gel under reducing conditions. A
unique band was visualized by Bio-Safe Coomassie stain
(Bio-Rad) and excised. Following trypsin digestion, the frag-
ments were analyzed on a ThermoFinnigan LTQ (Thermo
Scientific) tandem mass spectrometer. Spectra files were
analyzed with Sequest. Scaffold (Proteome Software Inc.,
Portland, OR)was used to compile and assign probability scores.RNA isolation and qRT-PCR
Cell populations were sorted directly into Trizol LS (Invitrogen).
First strand cDNA synthesis employed MMLV reverse transcrip-
tase and random oligonucleotide primers (both Invitrogen).
RNA levels were assessed by qRT-PCR using a Bio-Rad iCycler
and IQ5 detection system. All reactions were performed using
45 cycles of 0:15 at 95 °C, 0:20 at 68 °C and 0:25 at 72 °C.
Reaction mixtures included Platinum Taq DNA polymerase
(Invitrogen), 2.5 mM MgCl2, 10 μM 5′ and 3′ primers, 10 mM
dNTPs and 0.5x SYBR green. Primer sequences are listed in
Table S1. Gene expression levels were reported as the
difference between baseline-corrected, curve-fitted cycle
thresholds for the gene of interest minus the average cycle
thresholds of housekeeping genes GAPDH and/or beta-actin as
indicated. Curve-fitting of qRT-PCR cycle threshold results was
generated by IQ5 software (Bio-Rad) and statistical mean and
standard deviation data were determined with Microsoft Excel.Results
Identification and comparison of duct cell subpopu-
lations in the adult mouse pancreas and liver
To study adult mouse pancreatic progenitors and compare their
characteristics to their hepatic counterparts, cells were
obtained by sequential enzymatic tissue dispersal and labeled
with combinations of antibodies recognizing cell surface
antigens. Fig. 1 illustrates the sequential gating strategy used
to define subpopulations of mouse pancreatic (A) or hepatic (B)
cells. These gates allowed the exclusion of pancreatic acinar
cells or hepatocytes (high FSC/SSC), erythrocytes (low FSC/
SSC), leukocytes (CD45+/CD11b+) and endothelial cells (CD31+).
The percentage of cells labeled by duct cell surface marker
MIC1-1C3 (Dorrell et al., 2008) was substantially higher in
pancreatic than in liver tissue, as anticipated; the pancreas is
substantially more ductal than the liver. Sub-fractionation of
the MIC1-1C3+ population by CD133 and CD26 antigenicity
revealed that most cells were CD133+, but a smaller (~10%)
population of CD133−CD26+ cells was consistently observed.
qRT-PCR expression analysis (Fig. 2A) indicated that each
population consisted of KRT19+ duct cells, but that these were
heterogeneous for progenitor and mature gene expression
markers as previously observed in the liver (Dorrell et
al., 2011). Both the pancreatic and hepatic M+133+26−
subpopulations share a differentially high expression of
progenitor associated genes (Sox9/FoxJ1), and a collection of
transcriptional regulators recently implicated in epithelial cell
fate regulation (Ehf, Elf3, Grhl2) (Albino et al., 2012; Senga et
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Figure 1 Isolation and cultivation of organoid-forming cell subpopulations from pancreas and liver. Cells isolated from pancreas (A) or liver
(B) were enzymatically dispersed, antibody labeled and sorted by FACS. Successive gating shows sequential selection of cell-sized events (FSC
vs. SSC), non-doublets (FSC vs. pulse width), live cells (PI−), non-hematopoietic/endothelial events (CD45/CD11b/CD31−) and duct cells
(MIC1-1C3 subpopulations). (C) A representative image of a mouse pancreatic organoid culture initiated by M+133+26− cells (original
magnification 40×). (D,E) Flow cytometricmeasurement of duct-associated cell surfacemarkers on cells dispersed froman established organoid
culture. (F) qRT-PCR analyses of the levels of duct and progenitor-associated genes (relative to GAPDH) in pancreatic M+133+26− cells compared
to those from an organoid culture (at passage 6) they were used to establish. These values are the averages of three replicate amplifications.
278 C. Dorrell et al.al., 2012; Yamaguchi et al., 2010). Thus, the gene expression
phenotype of the organoid-initiating cell population was
consistent with that of a primitive duct cell type.Prospective isolation of pancreatic and hepatic
organoid-forming cells
We previously reported that among mouse hepatic duct
cells, only the MIC1-1C3+/CD133+/CD26− (M+133+26−) epi-
thelial subset contained 2D colony-forming progenitors
(Dorrell et al., 2011). Although useful, this assay suffered
from a limited capacity for self-renewal and was unsuitable
for the expansion of progenitor-initiated cells. Consequently,
we adopted the epithelial organoid assay developed by the
Clevers lab (Barker et al., 2010; Huch et al., 2013b) and used it
to assess the progenitor content of phenotypically-defined
pancreatic duct subpopulations.
The frequencies of organoid-forming cells detected in
FACS-sorted populations are listed in Table 1. For consistency
of enumeration, only organoids estimated to contain ≥500
cells at day 12 were scored as such. As had been observed in
the 2D colony assay, the M+133+26− fraction contained by far
the highest frequency of colony-forming cells; M+26+ duct cells
did not form organoids at a significant frequency. These same
patterns were observed with non-parenchymal liver cells, and
at similar frequencies. Thus, the mouse organoid forming
cells of liver (Huch et al., 2013b) and pancreas (Huch et al.,
2013a) can be prospectively isolated and studied using theM+133+26− labeling combination. The self-renewal capacity of
organoid-forming cells was assessed by secondary organoid
formation. Organoids derived from individually deposited and
microscopically confirmed FACS-sorted M+133+26− cells were
harvested on d12, dispersed to single cells by trypsinization
and re-seeded. Primary organoids which met the aforemen-
tioned size criteria yielded multiple daughter organoids N95%
of the time (after five independent sorts), indicating that
self-renewal potential was consistently maintained. Cell
cultures incapable of 10+ passages were excluded from the
analysis. Culture initiation frequencies were comparable in
single-cell (96w plated) and 1000-cell (24w plated) environ-
ments (Table 1), indicating environmental independence and
clonality. Pancreatic organoids were phenotypically very
ductal (Fig. 1C) as previously described (Huch et al., 2013a).
Although the surface phenotype of cultured organoid cells
remained primarily M+133+26− (Fig. 1D, E) andKrt19 expression
was similar to that of the parent population, the expression of
progenitor markers such as Sox9 was N10 fold lower (Fig. 1F).MIC1-1C3 binds to integrin alpha 3
MIC1-1C3 reactivity has been invaluable for the FACS isolation
of hepato-pancreatic duct cell subsets frommouse tissues. The
identification of the associated antigen and investigation of its
potential involvement in epithelial cell regulation was there-
fore of potential interest. Co-IP of protein lysate prepared from
a mouse cell line (H2.35) known to exhibit high reactivity with
Table 1 Quantification of organoid-forming progenitors in phenotypically defined pancreatic cell subpopulations.
Organ Population Organoids per
1000 input cells
SD Single-cell
deposition
Pancreas CD45/11b/31+ Blood/endothelium b1 na
CD45−11b−31− Non-blood/endothelium 4 2
CD45−11b−31−MIC1-1C3+ Duct cells 31 13
CD45−11b−31−MIC1-1C3− Non-duct cells 2.7 2
CD45−11b−31−MIC1-1C3+CD26+ Progenitor-depleted duct cells b1 na
CD45−11b−31−MIC1-1C3+133+26− Progenitor-enriched duct cells 44.6 14 1 in 19.7
Liver CD45/11b/31+ Blood/endothelium b1 na
CD45−11b−31− Non-blood/endothelium 3.3 3
CD45−11b−31−MIC1-1C3+CD26+ Progenitor-depleted duct cells 1.1 2
CD45−11b−31−MIC1-1C3+133+26− Progenitor-enriched duct cells 38.5 11 1 in 17.4
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Figure 2 Expression analysis of progenitor-enriched cell populations. (A) qRT-PCR was used to compare the expression of several
genes in the MIC1-1C3+ subpopulations of mouse liver and pancreas. Values shown are the averages of values from three pancreatic
and two liver samples, each analyzed three times by qRT-PCR. (B) Hierarchical clustering of RNA-seq derived expression values from
progenitor-enriched and depleted mouse pancreatic populations. (C) qRT-PCR analyses of twenty individual pancreatic M+133+26−
cells captured and processed using the Fluidigm C1 Single-Cell Auto Prep IFC. The levels of Sox9, Krt19 and Actb for each cell were
determined in three replicates, and amplified products were validated by electrophoresis. Sox9 and Krt19 expression levels are as
delta-Ct relative to Actb. (D) Hierarchical clustering of these same twenty cells on the basis of qRT-PCR-determined expression of
duct and associated genes. Expression is normalized per-gene, with red indicating the highest level(s).
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280 C. Dorrell et al.MIC1-1C3 yielded a band of approximately 120 kDa (Fig. S1A).
The list of possible targets revealed after band excision and
MALDI-TOF mass spectrometric identification is shown in Fig.
S1B. The two most strongly indicated proteins were integrin
beta 1 (ITGB1) and integrin alpha 3 (ITGA3), the two
components of the VLA3/CD49c complex. Of these, ITGA3
(molecular weight 117 kDa) matched most closely. RNA
expression levels supported this interpretation: ITGA3 mRNA
in MIC1-1C3+ cells from liver and pancreas was found to be
significantly higher than in MIC1-1C3− cells (Fig. S1C),
whereas ITGB1 mRNA levels were not significantly different
(Fig. S1D). A comparison of the labeling of MIC1-1C3 and a
polyclonal goat anti-CD49c antibody on consecutive
sections of pancreatic tissue (Fig. S1E, F) suggested that
the same cells were being marked, albeit with different
efficiencies.tation is therefore strong evidence for the absence of fusion.Gene expression in pancreatic
organoid-forming cells
The transcriptomes of FACS-isolated pancreatic cell popula-
tions from six different mice were assessed by RNA-seq and
compared to MIC1-1C3− (CD45−CD31−) pancreatic populations
from three mice. As shown in Fig. 2B, hierarchal clustering of
these samples reveals large blocks of genes with distinctive
expression in the organoid-forming populations compared to
non-ductal cells. Comparative analyses of theM+133+26− andM−
population pathways were performed using GSEA; KEGG output
is listed in Fig. S2A. Among the categories enriched in M+133+26−
cells are those known to be associated with duct function
(adherens, gap, and tight junctions) and cell proliferation (cell
cycle, DNA replication). DNA replication (Fig. S2B), mismatch
repair (Fig. S2C) and RIG1-like receptor signaling (Fig. S2D) had
nominal p values b 0.05, and are broken out in greater detail.
Although the M+133+26− fractions of mouse pancreas and
liver contain all of the organoid-forming activity, only a small
percentage of these cells actually initiate organoid cultures (as
previously described). This could be a stochastic process in
which the cells are essentially homogeneous but form
organoids by chance or due to some combination of environ-
mental factors, or because a more primitive subset exists
within the M+133+26− subpopulation. To examine this issue, we
performed single-cell analyses on individual M+133+26− cell
using a Fluidigm C1 apparatus and examined the expression
levels of Krt19, Amy2, Sox9, and Actb. In cells with readily
detectable beta actin (indicating efficient amplification of the
original mRNA) and keratin 19 (confirming the duct identity
of the examined cell) and with negligible or absent amylase
(i.e. non-acinar), Sox9 levels were highly variable (Fig. 2C). In
16/20 cells Sox9 was undetectable, and in the remaining cells
the expression of Sox9 varied over a 100-fold range. Thus, the
expression of this gene appears to vary from cell to cell within
the pancreatic M+133+26− subpopulation. Hierarchical cluster-
ing of these results plus those of duct markers Spp1, Slc28a3
and Pkhd1 (Fig. 2D) reveals considerable variability, with a
tendency for cells with high Sox9 expression to have lower
expression of other duct-associated genes. These results may
indicate true heterogeneity within this duct population or
reflect dynamic transcription within a relatively homogeneous
set of cells.Hepatic differentiation potential of pancreatic
organoid cells
One goal of epithelial progenitor expansion cultures is the
derivation of useful numbers of transplantable cells for the
treatment of human pathologies. We have previously shown
that hepatic organoids can produce hepatocytes upon trans-
plantation to Fah
−/−
mice (Huch et al., 2013b). Considering the
phenotypic and transcriptional similarities between the
organoid initiating cells from liver and pancreas, the similar
nature of the resulting organoid cultures, and evidence showing
the potential for pancreatic/hepatic lineage conversion (Rao et
al., 1986; Wang et al., 2001) we tested whether pancreatic
organoids could also give rise to hepatocytes after trans-
plantation. Fig. 3A illustrates the cell culture and trans-
plantation scheme. Pancreatic organoid cultures were
expanded to N100,000 cells per intended recipient mouse
then switched to a hepatocyte differentiation medium in
which Wnt3, Rspo1 and Noggin were withdrawn and DBZ,
Oncostatin M, IL-6, and HGF were administered for a 48 h
period. Recipient Alb-cre/Fah−/− and Fah−/−/Rag2−/−/Il2rg−/−
(FRG) animals were conditioned with a methionine/choline-
deficient and ethionine-supplemented (MCD + E) diet over the
same 48 h interval, with the intention of temporarily creating
a “progenitor-friendly” in vivo environment for transplanted
cells. This brief period in hepatocyte differentiation culture
was not sufficient to produce hepatocyte-associated gene
expression. As shown in Fig. 3B, cells remained very ductal and
do not express meaningful levels of albumin or HNF4a. The
intention of this strategy was to initiate the very earliest steps
of differentiation in vitro but allow most of the process to
occur in vivo. Pancreatic organoid transplants yieldedmultiple
FAH+ nodular grafts in half (5/10) of the recipient mice. Five
additional micewhich receivedMCD + E conditioning but were
transplanted with organoids that were not exposed to
differentiation culture failed to produce grafts, suggesting
that this was an important part of the process. Representative
examples of grafts in two different animals are illustrated
in Fig. 3C–J. Engrafted nodules expressed markers of hepato-
cyte identity (canalicular OC2-2G9, nuclear HNF4a, and
nuclear + cytoplasmic FAH) and exhibited characteristic
hepatocytic morphology. H&E staining of consecutive
sections of FAH + nodules revealed healthy tissue, lacking
the pale, vacuolar features of tyrosinemia found in
surrounding FAH-host liver. Engraftment levels were low
(~1% of liver mass), falling below the threshold for
therapeutic rescue, so it is unclear whether the engrafting
cells had hepatocyte function. The suitability of a
R26R-LacZ donor cells and Alb-cre Fah−/− recipients to
detect fusion-derived hepatocytes was confirmed by con-
trol experiments where R26R-mTmG hepatocytes or bone
marrow to an Alb-cre/Fah−/− recipient (Fig. S3). As we have
previously described (Willenbring et al., 2004), bone
marrow injection results in macrophage-hepatocyte fusion,
and viable fusion products with hepatocyte function are
selected by NTBC withdrawal in this model. Hepatocyte
transplantation (Fig. S3B) does not result in fusion as a
detectable frequency, but bone marrow/hepatocyte fusion
products are readily detectable. The absence of signal in Fah+
liver nodules after pancreatic R26R-LacZ organoid transplan-
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Figure 3 Pancreatic organoid cultures give rise to hepatocyte-like cells after transplantation to the livers of Fah−/− mice. (A) The
experimental design of pancreatic organoid culture and recipient mouse treatment to determine the potential for hepatocytic
differentiation. (B) Expression of duct and hepatocyte-associated genes measured by qRT-PCR. No significant differences in the pre-
and post-differentiation (pre-transplantation) expression of these genes were observed in two experiments (each sample examined
three times by qRT-PCR). (C–F) and (G–J) Representative examples of engrafted nodules identified in two different animals.
Immunofluorescent (OC2-2G9, FAH, HNF4a) detection and H&E staining were performed on adjacent sections of FFPE liver.
Arrowheads mark examples of properly organized bile canaliculi (I) and healthy hepatocyte-like cells (J), and an asterisk marks a
region of unhealthy, highly vacuolated hepatocytes highly invaded by inflammatory cells.
281The organoid-initiating cells in mouse pancreas and liver are similarInduction of insulin expression with endocrine
programming factors
The most obvious objective of pancreatic tissue cultivation is
the derivation of glucose-responsive insulin-expressing cells for
the cell replacement therapy of diabetes. To test whether this
highly expandable culture system could yield insulin-expressing
cells, we employed a tricistronic adenovector co-expressing
MafA, Pdx1, and Neurog3 (Akinci et al., 2012) and organoid
cultures derived from the pancreata of MIP-GFP transgenicmice(Hara et al., 2003). As shown in Fig. 4A, insulin (GFP) expression
was induced in late-passage MIP-GFP pancreatic organoid cells
(at a frequency of 5–22%) following tri-cistronic AdV adminis-
tration. These GFP+ (insulin promoter active) cells showed
transcriptional identity partially overlapping that of murine
beta cells (Fig. 4B), but with the retained expression of many
off-target (non-beta) genes. Nevertheless, the capacity of
organoid cultures for dramatic cell number expansion suggests
that a more refined reprogramming/differentiation methodol-
ogy could produce useful cells in unlimited numbers.
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Figure 4 Delivery of endocrine fate-specifying factors to expanded pancreatic organoid cultures yields insulin-expressing cells in
vitro. (A) GFP expression in MIP-GFP mouse pancreatic organoid cells 72 h after mock transduction or transduction with adenovirus
expressing mouse Pdx1, Neurog3 andMafA, measured by flow cytometry. (B–D) Expression of endocrine- and duct-associated genes in
Ad-PNM (Pdx1–Neurog3–MafA) treated pancreatic organoid cells relative to mouse islet cDNA, measured by qRT-PCR. Organoid cell
cDNA was recovered from the entire culture (GFP+ and GFP−).
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The roles of endogenous stem/progenitor cells in adult
pancreatic tissue homeostasis, acute/chronic injury re-
sponse and tumor initiation remain uncertain. However, it
is now clear that a subset of pancreatic duct cells are
capable of initiating long-term self-renewing organoid
cultures with effectively unlimited potential for expansion
in culture. The M+133+26− subsets of both the pancreas and
liver of adult mice contain the only cells with this capability.
Lgr5, which is a marker for self-renewing stem cells in the
colon, small intestine and stomach only becomes expressed
after injury in the adult liver and pancreas (Barker et al.,
2007, 2010; Huch et al., 2013a,b). Hence, in these latter
tissues Lgr5 is only a marker for activated progenitors and
cannot be used to prospectively identify clonogenic cells in
normal, uninjured tissue. Our study is the first to report the
prospective purification of “inactive” pancreatic and liver
mouse organoid forming progenitors. We applied population
expression profiling with RNA-seq and single cell analyses to
determine the transcriptomes and transcriptional heteroge-
neity of these important populations. The ability to purify
both inactive and injury-activated progenitors will permit
the study of the molecular circuitry underlying progenitor
activation in the future.
Although heterogeneity of pancreatic ducts has long been
known based on morphological criteria, we demonstrate here
for the first time that pancreatic duct cells are heterogeneous
in terms of clonogenic potential. Thus it is appropriate to
distinguish between clonogenic and non-clonogenic ducts. Thesurface marker combinations used herein do not permit the
unambiguous identification of these duct subsets in histological
sections. Hence, we currently do not know whether clonogenic
and non-clonogenic ducts reside in anatomically distinct
locations or whether they are intermingled and lie adjacent to
each other. Our RNA-seq analysis represents a list of distinctive
markers that could be used to localize the progenitors in tissue
sections and generate lineage-tracing tools in the future. The
observation of high Sox9 expression in only a small subset of
M+133+26− is interesting, and it is tempting to speculate that
this property is predictive of their organoid-forming capacity.
We note that heterogeneity of Sox9 at the protein level has
recently been reported in epithelial tissues. Ramalingam et al.
found that intestinal epithelial cells express Sox9 at distinct
levels, and that only the highest expressing subpopulation had
progenitor activity (Ramalingam et al., 2012).
We have recently shown that gall bladder derived epithelial
cells can be reprogrammed to become endocrine-like and
express insulin using a combination of Pdx1, Ngn3 and MafA
(Hickey et al., 2013). Others have shown that biliary duct cells
in the liver can be reprogrammed in vivo and cure diabetes
in mice (Akinci et al., 2012). Here we demonstrate that
pancreatic duct cells can similarly be reprogrammed even
after massive expansion in organoid culture. The expandabil-
ity of the pancreatic progenitors makes them a potential
target for generating transplantable beta cells. Ducts and
acinar cells are routine by-products of islet isolation proce-
dures using in clinical transplantation (Baeyens and Bouwens,
2008). Recently, the laboratory of S. Kim has shown that
human ducts can also be reprogrammed to become functional
283The organoid-initiating cells in mouse pancreas and liver are similarbeta-like cells (Lee et al., 2013). Therefore, the progenitor
population described here may have potential utility in beta
cell replacement therapy for diabetes.
The common phenotype and similar frequencies of the
pancreatic and liver organoid initiating cells, and the
observation that pancreas-derived progenitors can generate
hepatocyte-like cells in an appropriate context provides yet
more evidence for the commonality of these tissues. One
implication is that pancreatic tissue could be a source (or
location) for the restoration of lost liver function and vice
versa. Additional study of the regulatory events that specify
hepatic or pancreatic differentiation from these progenitors
will be needed to test these ideas.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.07.006.
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